09/20/2019
Bio-Rad announces that it has joined the European Molecular Biology Laboratory (EMBL) Corporate Partnership Programme, to help expand EMBL’s innovative portfolio of scientific training courses designed for budding young
09/18/2019
New to Bio-Rad's Explorer Program, the Science of Opioid Dependence Kit is an entry-level bridge between DNA electrophoresis & PCR — a new way of teaching genetics in the context of a current crisis: the opioid crisis.
07/14/2019
The Multiplex Panel Covers Biologically-Researched Cytokine Targets Associated with Immunotherapy Research
07/11/2019
Bio-Rad’s Reliance One-Step Multiplex Supermix is a highly sensitive and robust reagent mix for detection and quantification of up to five RNA or DNA targets in one reaction.
07/10/2019
Scientists at the 2019 ASCO Annual Meeting presented research that relied on Droplet Digital PCR to explore the strengths and limitations of using circulating tumor DNA as a biomarker for predicting outcomes and guiding
06/25/2019
Nature Biotechnology recently published joint research from Bio-Rad and Harvard featuring Bio-Rad’s new single-cell ATAC-Seq solution.
03/29/2019
Several research studies supporting the clinical utility of ddPCR powered liquid biopsy will be presented during this year’s AACR Annual Meeting.
02/14/2019
Bio-Rad’s QXDx AutoDG ddPCR System is now an FDA-cleared diagnostic solution available for monitoring molecular response in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
02/01/2019
Bio-Rad’s ZE5 Cell Analyzer is now automation-ready.
01/20/2019
During a Bio-Rad workshop at PMWC, panelists will discuss how Droplet Digital PCR helps physicians monitor immunotherapy effectiveness in patients.